THE AYURVEDIC TREATMENT OF SHWETA PRADARA (LEUCORRHOEA) -CASE REPORT
The fast-evolving present era is not only upfront in the case of technological developments but has also been at the top for the manifestation of lifestyle disorders. The most excellent method to prevent sickness is to adopt healthy behaviours. But nowadays, healthy living is seldom practised due to the complexity of a woman's eve-ryday existence. A woman's vaginal health is just as vital as her general health. A lady in good health is a guar-antee of a long life. Every stage and period of a woman's life involves physical and psychological transitions. She also has a dual obligation to take care of her family and her career. She must thus be in excellent physical and mental condition. A healthy yoni is essential to a woman's ability to live a safe, healthy, and confident life. An infection can bring inflammation of the vagina or a shift in the usual ratio of yeast and bacteria in the vagina. Shweta pradara is a bothersome symptom that can be a complication in various disorders. Shweta Pradara is a symptom, not a disease. Hence, its etiopathogenesis would coincide with that of the primary illness. It is possi-ble to say that it is an Apana Vayu-regional Kaphaja disease. White discharge can also result from infections in the uterus and vagina caused by specific organisms. Here, a case report of a female patient having complaints of thick white discharge P/V, burning in the vaginal area, burning micturition, low back ache and constipation has been presented. Shamana Chikitsa and Yoni Prakshalana treated a female patient with Shweta Pradara. With the foregoing regimen, she had significant symptom alleviation. A successfully treated case using Shamana Oushadhis will be discussed in this article.
Authors
- K. Kapoor
Publication Details
- Journal
- International Ayurvedic Medical Journal
- Published
- 2025-02-15
- DOI
- https://doi.org/10.46607/iamj5013022025
- Primary Topic
- Phytochemicals and Medicinal Plants
- Type
- article
- Field-Weighted Citation Impact
- 0.00